Stereotactic body radiotherapy for oligometastatic soft tissue sarcoma

Authors:

Abstract
Stereotactic body radiotherapy (SBRT) is emerging as a novel treatment option in metastatic soft tissue sarcoma (STS). The aim of our study was to evaluate the effectiveness of exclusive SBRT on disease control and survival in oligometastatic (≤ 3 synchronous lesions) STS.

This publication has 22 references indexed in Scilit: